Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- PMS Study to Verify Usefulness of Taiho's TS-1
July 1, 2002
- Sales of Radicut Exceed MPC's Expectation
July 1, 2002
- New GCP GL Fully Applied in Most Clinical Trials At Present
July 1, 2002
- WEBSITE NEWS
June 24, 2002
- Sugi Pharmacy Installs Clean Benches in Drugstores
June 24, 2002
- BUSINESS NEWS IN BRIEF
June 24, 2002
- Terumo: Glucose Meter with Voice Guide Function
June 24, 2002
- Kusuri Provervs Reveal Japanese Spirit (11)
June 24, 2002
- J&J Sponsors Seminar on Shunt Intervention
June 24, 2002
- 29 Products Including Zomig RM Added to NHI List
June 24, 2002
- Medtronic, Baxter Present Reports on Products Using Swine Heart Valves
June 24, 2002
- Establishment of Fast-track System Requested Again by FPMAJ: PAL Hearings
June 24, 2002
- MEDICAL DEVICE NEWS IN BRIEF
June 24, 2002
- Iressa Recommended for Approval by CDFS Panel
June 24, 2002
- BD: New M. tuberculosis Susceptibility Testing Reagent
June 24, 2002
- Science and Technology White Paper Stresses Importance of Innovation
June 24, 2002
- MBL Gets License from Oncotherapy Science
June 24, 2002
- Precautions against Stevens-Johnson Syndrome Issued Again
June 24, 2002
- DIAGNOSTIC NEWS IN BRIEF
June 24, 2002
- 46 Active Ingredients Listed for Quality Reevaluation
June 24, 2002
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…